Pharmacological characterization of F-180: a selective human V(1a) vasopressin receptor agonist of high affinity

Por Andrés, Miriam, Trueba, Miguel, Guillon, Gilles
Publicado em 2002

Vasopressin Inhibits LTP in the CA2 Mouse Hippocampal Area

Por Chafai, Magda, Corbani, Maithé, Guillon, Gilles, Desarménien, Michel G.
Publicado em 2012

Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation

Por Oligny-Longpré, Geneviève, Corbani, Maithé, Zhou, Joris, Hogue, Mireille, Guillon, Gilles, Bouvier, Michel
Publicado em 2012

Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration

Por Colson, Pascal H, Bernard, Cedric, Struck, Joachim, Morgenthaler, Nils G, Albat, Bernard, Guillon, Gilles
Publicado em 2011

Design, synthesis and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors

Por Corbani, Maithé, Trueba, Miguel, Stoev, Stoytcho, Murat, Brigitte, Mion, Julie, Boulay, Véra, Guillon, Gilles, Manning, Maurice
Publicado em 2011

A GIPC1-Palmitate Switch Modulates Dopamine Drd3 Receptor Trafficking and Signaling

Por Arango-Lievano, Margarita, Sensoy, Ozge, Borie, Amélie, Corbani, Maithé, Guillon, Gilles, Sokoloff, Pierre, Weinstein, Harel, Jeanneteau, Freddy
Publicado no Mol Cell Biol (2016)

V1b and CRHR1 Receptor Heterodimerization Mediates Synergistic Biological Actions of Vasopressin and CRH

Por Murat, Brigitte, Devost, Dominic, Andrés, Miriam, Mion, Julie, Boulay, Véra, Corbani, Maithé, Zingg, Hans H., Guillon, Gilles
Publicado no Mol Endocrinol (2012)

Pharmacological characterization of FE 201874, the first selective high affinity rat V(1A) vasopressin receptor agonist

Por Marir, Rafik, Virsolvy, Anne, Wisniewski, Kazimierz, Mion, Julie, Haddou, Dominique, Galibert, Evelyne, Meraihi, Zahia, Desarménien, Michel G, Guillon, Gilles
Publicado em 2013